Skip to Main Content

Paper Details

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.
Cell Rep
77
2021
Author NameAffiliation
Jennifer R HamiltonUniversity of California, USA Innovative Genomics Institute berkeley
David N NguyenInnovative Genomics Institute, University of California, USA Diabetes Center, USA Gladstone Institutes san francisco
Brian R ShyInnovative Genomics Institute, University of California, USA Diabetes Center, USA Gladstone Institutes san francisco
Alexander MarsonInnovative Genomics Institute, University of California, USA Diabetes Center, USA Gladstone Institutes, USA Parker Institute for Cancer Immunotherapy, USA Helen Diller Family Comprehensive Cancer Center san francisco
Jennifer A DoudnaUniversity of California, USA Innovative Genomics Institute, USA University of California, Berkeley-University of California, USA Gladstone Institutes, USA Howard Hughes Medical Institute, USA California Institute for Quantitative Biosciences (QB3), Lawrence Berkeley National Laboratory
  • 1 - 5

Datasets